Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Bridgeford Group was a boutique investment banking firm that specialized in providing merger and acquisition (M&A) advisory services, particularly within the healthcare, life sciences, and technology sectors. Founded in 1991, the firm became well-regarded for its strategic advice to middle-market companies and large corporations seeking to navigate complex transactions in the pharmaceutical and biotechnology industries. The company was eventually acquired by Mizuho Financial Group to serve as its primary M&A advisory arm in the United States. Following the acquisition, its operations were integrated into Mizuho's global investment banking platform, where it continued to facilitate significant deals in the healthcare space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Bridgeford Group.